Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The impact of non-pharmaceutical interventions on the prevention and control of COVID-19 in New York City

Jiannan Yang, View ORCID ProfileQingpeng Zhang, Zhidong Cao, View ORCID ProfileJianxi Gao, Dirk Pfeiffer, Lu Zhong, Daniel Dajun Zeng
doi: https://doi.org/10.1101/2020.12.01.20242347
Jiannan Yang
1School of Data Science, City University of Hong Kong, Hong Kong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qingpeng Zhang
1School of Data Science, City University of Hong Kong, Hong Kong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Qingpeng Zhang
  • For correspondence: qingpeng.zhang@cityu.edu.hk dajun.zeng@ia.ac.cn
Zhidong Cao
2The State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China
3School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China
4Shenzhen Artificial Intelligence and Data Science Institute (Longhua), Shenzhen, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianxi Gao
5Department of Computer Science, Rensselaer Polytechnic Institute, Troy, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jianxi Gao
Dirk Pfeiffer
6Department of Infectious Diseases and Public Health, City University of Hong Kong, Hong Kong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lu Zhong
7Department of Mechanical, Aerospace, and Nuclear Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Dajun Zeng
2The State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China
3School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China
4Shenzhen Artificial Intelligence and Data Science Institute (Longhua), Shenzhen, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: qingpeng.zhang@cityu.edu.hk dajun.zeng@ia.ac.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The emergence of coronavirus disease 2019 (COVID-19) has infected more than 37 million people worldwide. The control responses varied across countries with different outcomes in terms of epidemic size and social disruption. In this study, we presented an age-specific susceptible-exposed-infected-recovery-death model that considers the unique characteristics of COVID-19 to examine the effectiveness of various non-pharmaceutical interventions (NPIs) in New York City (NYC). Numerical experiments from our model show that the control policies implemented in NYC reduced the number of infections by 72% (IQR 53-95), and the number of deceased cases by 76% (IQR 58-96) by the end of 2020, respectively. Among all the NPIs, social distancing for the entire population and the protection for the elderly in the public facilities is the most effective control measure in reducing severe infections and deceased cases. School closure policy may not work as effectively as one might expect in terms of reducing the number of deceased cases. Our simulation results provide novel insights into the city-specific implementation of NPIs with minimal social disruption considering the locations and population characteristics.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported in part by grants from the National Natural Science Foundation of China (72042018).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not applicable

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The source codes have been made available on Github: https://github.com/JasonJYang/Age-specific-SEIRD.

https://github.com/JasonJYang/Age-specific-SEIRD

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 03, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The impact of non-pharmaceutical interventions on the prevention and control of COVID-19 in New York City
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The impact of non-pharmaceutical interventions on the prevention and control of COVID-19 in New York City
Jiannan Yang, Qingpeng Zhang, Zhidong Cao, Jianxi Gao, Dirk Pfeiffer, Lu Zhong, Daniel Dajun Zeng
medRxiv 2020.12.01.20242347; doi: https://doi.org/10.1101/2020.12.01.20242347
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The impact of non-pharmaceutical interventions on the prevention and control of COVID-19 in New York City
Jiannan Yang, Qingpeng Zhang, Zhidong Cao, Jianxi Gao, Dirk Pfeiffer, Lu Zhong, Daniel Dajun Zeng
medRxiv 2020.12.01.20242347; doi: https://doi.org/10.1101/2020.12.01.20242347

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (270)
  • Allergy and Immunology (552)
  • Anesthesia (135)
  • Cardiovascular Medicine (1760)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (660)
  • Epidemiology (10799)
  • Forensic Medicine (8)
  • Gastroenterology (592)
  • Genetic and Genomic Medicine (2950)
  • Geriatric Medicine (287)
  • Health Economics (534)
  • Health Informatics (1929)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (292)
  • HIV/AIDS (630)
  • Infectious Diseases (except HIV/AIDS) (12518)
  • Intensive Care and Critical Care Medicine (692)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2799)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1467)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (866)
  • Pharmacology and Therapeutics (366)
  • Primary Care Research (337)
  • Psychiatry and Clinical Psychology (2640)
  • Public and Global Health (5370)
  • Radiology and Imaging (1013)
  • Rehabilitation Medicine and Physical Therapy (596)
  • Respiratory Medicine (726)
  • Rheumatology (330)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (125)